Back

Analysis of first plus recurrent cardiovascular (CV) and hospitalisation events in the CAROLINA trial

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Improving Cardiovascular Function and Clinical Outcome in Diabetes Using New Guideline-Based Pharmacotherapy Antidiabetic Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

7 More presentations in this session

Presentation thumbnail
Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial.
Doctor G. Ferrannini (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Cardiovascular outcomes in patients with type 2 diabetes and reduced eGFR and albuminuria: a REWIND post hoc subgroup analysis
Professor H. Colhoun (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Direct effects of canagliflozin on human myocardial redox signalling: a novel role for SGLT1 inhibition
Doctor H. Kondo (Yufu City, JP)
Abstract Slides Video
Presentation thumbnail
Impact of polyvascular disease and renal dysfunction on cardiovascular outcomes in diabetes: post hoc analyses from EMPA-REG OUTCOME
Professor S. Verma (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Natriuretic effect of 2 weeks of dapagliflozin treatment in patients with type 2 diabetes and preserved kidney function: results of the DAPASALT trial
Professor H. Heerspink (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Improving Cardiovascular Function and Clinical Outcome in Diabetes Using New Guideline-Based Pharmacotherapy

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Session
Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
thumbnail
Congress Session
Diabetes and the heart: pharmacotherapy (1)
thumbnail
Congress Session
2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources